Gastrointestinal bleeding: Endoscopic cyanoacrylate therapy for gastric variceal bleeding

Nature Reviews Gastroenterology and Hepatology

Volumn 7, Issue 4, 2010, Pages 190-191

  McAvoy, Norma C ^a   Hayes, Peter C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOACRYLATE; ENBUCRILATE; SCLEROSING AGENT; THROMBIN; TISSUE ADHESIVE;

COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; ENDOSCOPIC THERAPY; GASTROSCOPY; HEPATIC ENCEPHALOPATHY; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; STOMACH HEMORRHAGE; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

CYANOACRYLATES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; INJECTIONS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SURVIVAL RATE; TISSUE ADHESIVES; TREATMENT OUTCOME;

EID: 77950822033     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.22     Document Type: Short Survey

References (11)

1. Kim, T. et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 25, 307-312 (1997). (Pubitemid 27069047)
2. sarin, K. et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16, 1343-1349 (1992).
3. Lo, G. H., Lai, K. H., Cheng, J. s., Chen, M. H. & Chiang, H. T. A prospective randomised control trial of butyl cyanoacrylate injection verses band ligation in the management of bleeding gastric varices. Hepatology 33, 1060-1064 (2001).
4. Chao, Y. et al. Hepatic hemodynamics features in patients with esophageal or gastric varices. J. Hepatol. 19, 85-89 (1993). (Pubitemid 23338015)
5. Procaccini, n. J., Al-Osaimi, A. M., northup, P., Argo, C. & Caldwell, s. H. endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U. s. analysis. Gastrointest. Endosc. 70, 881-887 (2009).
6. Lo, G. H. et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic stent shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 39, 679-685 (2007).
7. Jalan, R., elton, R. A., Redhead, D. n., Finlayson, n. D., & Hayes, P. C. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent shunt for variceal haemorrhage. J. Hepatol. 23, 123-128 (1995).
8. nolte, w. et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic stent shunt in patients with cirrhosis; clinical, laboratory, psychometric and electoencephalopathic investigations. Hepatology 28, 1215-1225 (1998). (Pubitemid 28493830)
9. Rosado, B. & Kamath, P. s. Transjugular intrahepatic portosystemic stent shunts: an update. Liver Transpl. 9, 207-217 (2003). (Pubitemid 36322321)
10. somberg, K. A. et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic stent shunts: incidence and risk factors. Am. J. Gastroenterol. 90, 549-555 (1995).
11. Mahadeva, s., Bellamy, M. C., Kessel, D., Davies, M. H. & Millson, C. e. Costeffectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am. J. Gastroenterol. 98, 2688-2693 (2003). (Pubitemid 38020109)